title: SBRT Treatment of Metachronous Small-Cell and Non-Small-Cell Lung Carcinomas in a Patient with Severe COPD.
abstract: Stereotactic body radiotherapy (SBRT) has not been widely employed in the treatment of limited-stage (LS) small-cell lung cancer (SCLC), although SBRT finds particular utility in patients medically unfit to undergo surgical resection or radiotherapy with conventional fields. The authors present the case of a 61-year-old female smoker with severe chronic obstructive pulmonary disease (COPD), diagnosed incidentally with LS-SCLC. Concurrent chemoradiotherapy was contraindicated by her poor pulmonary function, and she was treated radically with four cycles of cisplatin and etoposide chemotherapy. This was followed by prophylactic cranial irradiation and consolidative SBRT (48 Gy in 4 fractions) to the residual tumour, which achieved a complete clinical response. Fifteen months following the patient's initial diagnosis, a metachronous Stage IA contralateral non-small cell lung cancer (NSCLC) was incidentally diagnosed and was treated with SBRT (48 Gy in 4 fractions). Although studies have established that the incidence of a second lung cancer is higher in patients with previous SCLC, this case is unique in that both primaries were treated with SBRT.
authors.affiliation: Radiation Oncology, Cross Cancer Center, University of Alberta.
authors.forename: Adele
authors.initials: A
authors.lastname: Duimering
authors.affiliation: Radiation Oncology, Cross Cancer Center, University of Alberta.
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Gabos
authors.affiliation: Radiation Oncology, Cross Cancer Center, University of Alberta.
authors.forename: Brock
authors.initials: B
authors.lastname: Debenham
keywords: copd; non-small cell lung carcinoma; radiotherapy; small cell lung cancer; stereotactic body radiotherapy
references.citation: Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1092-9
references.pmid: 24661663
references.citation: J Thorac Cardiovasc Surg. 2010 Aug;140(2):377-86
references.pmid: 20400121
references.citation: J Thorac Oncol. 2009 Sep;4(9):1049-59
references.pmid: 19652623
references.citation: Nat Rev Cancer. 2013 Apr;13(4):233-45
references.pmid: 23467302
references.citation: J Radiat Res. 2013 Jan;54(1):108-12
references.pmid: 22923748
references.citation: N Engl J Med. 1992 Dec 3;327(23):1618-24
references.pmid: 1331787
references.citation: Ann Saudi Med. 2010 May-Jun;30(3):236-8
references.pmid: 20427942
references.citation: J Natl Cancer Inst. 1998 Sep 16;90(18):1335-45
references.pmid: 9747865
references.citation: Asian Cardiovasc Thorac Ann. 2014 Sep;22(7):865-8
references.pmid: 24887854
references.citation: J Clin Oncol. 2009 Jul 10;27(20):3290-6
references.pmid: 19414667
references.citation: Clin Lung Cancer. 2015 Jan;16(1):15-23
references.pmid: 25246383
references.citation: Semin Surg Oncol. 2003;21(2):74-84
references.pmid: 14508857
references.citation: Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1149-56
references.pmid: 21640513
references.citation: Semin Oncol. 2005 Apr;32(2 Suppl 3):S111-3
references.pmid: 16015546
references.citation: Am J Clin Oncol. 2011 Oct;34(5):494-8
references.pmid: 20805737